Sentences with phrase «biotechnology company creating»

UNITY Biotechnology Appoints Additional Biotech Industry Veterans to Executive Team September 21, 2017 SAN FRANCISCO, Sept. 21, 2017 / PRNewswire / — UNITY Biotechnology, Inc. («UNITY»), a privately held biotechnology company creating therapeutics that prevent, halt, or reverse numerous diseases of aging, today announced recent additions to its executive team.
UNITY Biotechnology Announces Extension of Series B Financing Bringing Total Round to $ 151 Million August 17, 2017 SAN FRANCISCO, August 17, 2017 / PRNewswire / — UNITY Biotechnology, Inc. («UNITY»), a privately held biotechnology company creating therapeutics that prevent, halt, or reverse numerous diseases of aging, today announced the closing of an additional $ 35 million in Series B financing.

Not exact matches

«Far and away the biggest value - creating step that a company can have is evolving from concept to drug,» says Brian Bapty, a biotechnology analyst with Vancouver - based brokerage Raymond James Financial Inc. «It's one of the best businesses to be in, albeit one of the higher - risk businesses.»
Editas, along with other biotechnology companies, want to use CRISPR as a way to potentially create some.
In his «lessons learned» article, Wilson advises researchers against putting themselves in situations that might create potential financial conflicts (in 1992 Wilson had founded a biotechnology company focused on gene therapy).
Whether the work is done at government institutions, universities or drug companies, the biotechnology boost to vaccine research is creating new opportunities to do vital work.
A team of scientists at the University of Washington and the biotechnology company Illumina have created an innovative tool to directly detect the delicate, single - molecule interactions between DNA and enzymatic proteins.
Both books also tackle the resulting shift in ethical, aspirational, and legal landscapes in biomedical research as molecular scientists rushed to form industrial ties, universities accelerated patenting and licensing activities, and entrepreneurs created biotechnology companies.
Survey respondents voted into second place Monsanto Company, a company that applies biotechnology as well as traditional chemistry to create and manufacture its agricultural prCompany, a company that applies biotechnology as well as traditional chemistry to create and manufacture its agricultural prcompany that applies biotechnology as well as traditional chemistry to create and manufacture its agricultural products.
As Science Careers noted 5 years ago, a group of young scientists at WUSTL took matters into their own hands, creating the volunteer - run BALSA (or Biotechnology and Life Sciences Advising) Group, which hires out five - person interdisciplinary teams — sometimes including law or business students along with scientists — to do approximately 6 - week - long consulting projects for companies, universities, and other organizations.
«We have a more than century - old tradition of generating successful pharmaceutical companies and conducting clinical trials, and a decade of experience in creating biotechnology companies,» says Ole Frijs - Madsen, Director of Invest in Denmark (IDK).
«Since the inception of the University - Industry Liaison Office [UILO] in 1984, UBC has spun off 91 companies, while raising more than CA$ 1.3 billion from private investors,» says Paul Stinson, executive director of BC Biotech, an organization created 10 years ago to promote and aid the development of biotechnology in BC.
Now life imitates art: A French biotechnology company has created a transgenic tadpole that fluoresces when it encounters chemical contaminants in water that disrupt thyroid functioning.
Many biotechnology companies place so much emphasis on getting new products through the pipeline and into the marketplace that they create a nonstop challenge zone for their employees.
To find out, Xueping Chen and colleagues at Vitargent, a biotechnology company in Hong Kong, have created a genetically engineered fish that glows green when it is exposed to oestrogen - like chemicals.
CAMBRIDGE, Mass., April 27, 2017 — Moderna Therapeutics, a clinical stage biotechnology company that is pioneering messenger RNA (mRNA) Therapeutics ™ to create a new generation of transformative medicines for patients, today announced positive interim data from an ongoing Phase 1 study of mRNA - 1440, an mRNA infectious disease vaccine against avian H10N8 influenza, demonstrating mRNA - 1440 induced high levels of immunogenicity, and was safe and well tolerated.
Created in 2006, BioWin, the Health Cluster of Wallonia (Belgium), is the reference player for all the stakeholders (companies, research centers and universities) involved in innovative R&D projects and / or skills development in the field of health biotechnology and medical technologies.
CAMBRIDGE, Mass., July 13, 2017 — Moderna Therapeutics, a clinical stage biotechnology company that is pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced new data demonstrating that its Zika mRNA vaccine prevented Zika virus transmission from pregnant mice to their fetuses.
Creating Biotechnology Solutions Who is SemBioSys SemBioSys Genetics Inc. is a plant biotechnology company with a powerful technology that enables production of high - value pharmaceutical and non-pharmaceutical products in an affordable and sustaiBiotechnology Solutions Who is SemBioSys SemBioSys Genetics Inc. is a plant biotechnology company with a powerful technology that enables production of high - value pharmaceutical and non-pharmaceutical products in an affordable and sustaibiotechnology company with a powerful technology that enables production of high - value pharmaceutical and non-pharmaceutical products in an affordable and sustainable manner.
Along with colleagues, he founded Ontogeny Inc., a biotechnology company based in Cambridge, Massachusetts that aims to use developmental biology approaches to create new treatments for diseases such as diabetes and Parkinson's.
Creating a culture in which biotechnology companies are a vehicle to unlock value is key to bringing benefits rapidly to our patients.
Increased understanding of the developing brain and how deviations from normal development can increase the risk of neurological and psychiatric diseases has created a rich landscape of opportunity for collaborations between leading academic medical centers and pharmaceutical and biotechnology companies dedicated to identifying new drugs and other interventions to help children.
Dr. Goeddel is currently Managing Partner of The Column Group, a leading venture capital firm dedicated to creating the next generation of biotechnology companies.
Pollack notes that such clashes have become much more common in recent months as the stock market crash has pushed the market capitalization of many biotechnology companies to less than the cash on hand, which creates an opportunity for investors to realize an immediate return if the company dissolves.
She is an Artist - in - Residence at EpiBone, a biotechnology company based in Brooklyn, creating drawings from life for the first time in her career.
PROFESSIONAL SUMMARY Thermo Fisher Scientifc, CA Mar 2017 - Present Marketing Automation developer Thermo Fisher Scientific is an American multinational, biotechnology product development company, created in 2006 by the merger of Thermo Electron and Fisher Scientific.
Professional Duties & Responsibilities Biomedical and biotechnology engineer with background in design of biomaterials, biosensors, drug delivery devices, microfrabrication, and tissue engineering Working knowledge of direct cell writing and rapid prototyping Experience fabricating nanocomposite hydrogel scaffolds Proficient in material analysis, mechanical, biochemical, and morphological testing of synthetic and biological materials Extensive experience in bio-imaging processes and procedures Specialized in mammalian, microbial, and viral cell culture Working knowledge of lab techniques and instruments including electrophoresis, chromatography, microscopy, spectroscopy, PCR, Flow cytometery, protein assay, DNA isolation techniques, polymer synthesis and characterization, and synthetic fiber production Developed strong knowledge of FDA, GLP, GMP, GCP, and GDP regulatory requirements Created biocompatible photocurable hydrogels for cell immobilization Formulated cell friendly prepolymer formulation Performed surface modification of nano - particle fillers to enhance their biocompatibility Evaluated cell and biomaterial interaction, cell growth, and proliferation Designed bench - top experiments and protocols to simulate in vivo situations Designed hydrogel based microfluidic prototypes for cell entrapment and cell culture utilizing computer - aided robotic dispenser Determined various mechanical, morphological, and transport properties of photocured hydrogels using Instron, FTIR, EDX, X-ray diffraction, DSC, TGA, and DMA Assessed biocompatibility of hydrogels and physiology of entrapped cells Evaluated intracellular and extracellular reactions of entrapped cells on spatial and temporal scales using optical, confocal, fluorescence, atomic force, and scanning electron microscopies Designed various biochemical assays Developed thermosensitive PET membranes for transdermal drug delivery application using Gamma radiation induced graft co-polymerization of N - isopropyl acylamide and Acrylic acid Characterized grafted co-polymer using various polymer characterization techniques Manipulated lower critical solution temperature of grafted thermosensitive co-polymer Loaded antibiotic on grafted co-polymer and determined drug release profile with temperature Determined biomechanical and biochemical properties of biological gels isolated from marine organisms Analyzed morphological and mechanical properties of metal coated yarns using SEM and Instron Performed analytical work on pharmaceutical formulations using gas and high performance liquid chromatography Performed market research and analysis for medical textile company Developed and implement comprehensive marketing and sales campaign
«Companies may be looking to create and commercialize new products for blood tests — anything that you can imagine that falls within the life sciences or biotechnology sector.»
In addition to having the most temperate weather in the United States, San Diego is also one of the top regions in the country for biotechnology companies, which creates billions of dollars to the local economy.
a b c d e f g h i j k l m n o p q r s t u v w x y z